Aktionsplan Neurocrine Biosciences
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen
Neurocrine Biosciences является публичной биофармацевтической компанией, основанной в 1992 году. Головной офис компании находится в Сан-Диего, штат Калифорния, и возглавляет генеральный директор Кевин Горман. Нейрокрин разрабатывает методы лечения неврологических и эндокринных заболеваний и расстройств.Цена ао | 124.33 |
---|---|
P/E | 284.04 |
P/S | 13.34 |
P/BV | 16.5 |
EV/EBITDA | 48.07 |
EBITDA | 0.2266 |
Сайт | http://www.neurocrine.com |
Число акций ао | 0.101 млрд |
Выручка | 0.7881 |
Див.доход ао | 0 |
ISIN | US64125C1099 |
Валюта | usd |
IPO date | 1996-05-23 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Preisänderung pro Tag: | -0.1446% (124.51) |
---|---|
Preisänderung pro Woche: | +10.6% (112.41) |
Preisänderung pro Monat: | +1.65% (122.31) |
Preisänderung über 3 Monate: | -14.66% (145.69) |
Preisänderung über sechs Monate: | -6.98% (133.66) |
Preisänderung pro Jahr: | +11.89% (111.12) |
Preisänderung über 3 Jahre: | +45.42% (85.5) |
Preisänderung über 5 Jahre: | +9.92% (113.11) |
Preisänderung über 10 Jahre: | +163.91% (47.11) |
Preisänderung seit Jahresbeginn: | +9.62% (113.42) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Transaktionsdatum | Offenlegungsdatum | Insider | Typ | Preis | Volumen | Menge | Teilen bis zu, % | Danach teilen, % | Dokumentieren |
---|---|---|---|---|---|---|---|---|---|
16.07.2024 | 18.07.2024 | Cooke Julie Chief Human Resources Officer |
Verkauf | 150.04 | 135 036 | 900 | 0 | 0 | Link |
16.07.2024 | 18.07.2024 | Cooke Julie Chief Human Resources Officer |
Kaufen | 61.82 | 55 638 | 900 | 0 | 0 | Link |
01.07.2024 | 02.07.2024 | Delaet Ingrid Chief Regulatory Officer |
Verkauf | 138.11 | 37 566 | 272 | 0 | 0 | Link |
01.07.2024 | 02.07.2024 | Delaet Ingrid Chief Regulatory Officer |
Kaufen | 79.02 | 21 493 | 272 | 0 | 0 | Link |
01.07.2024 | 02.07.2024 | Cooke Julie Chief Human Resources Officer |
Verkauf | 140.19 | 1 401 900 | 10000 | 0 | -0.01 | Link |
01.07.2024 | 02.07.2024 | Cooke Julie Chief Human Resources Officer |
Kaufen | 61.82 | 618 200 | 10000 | 0 | 0.01 | Link |
08.02.2024 | 08.02.2024 | ABERNETHY MATT Chief Financial Officer |
Verkauf | 134.21 | 131 526 | 980 | 0 | 0 | Link |
08.02.2024 | 08.02.2024 | BENEVICH ERIC Chief Commercial Officer |
Verkauf | 134.19 | 131 506 | 980 | 0 | 0 | Link |
08.02.2024 | 08.02.2024 | Gano Kyle Chief Business Development Off |
Verkauf | 134.2 | 131 516 | 980 | 0 | 0 | Link |
08.02.2024 | 08.02.2024 | GORMAN KEVIN CHARLES Chief Executive Officer |
Verkauf | 134.15 | 305 057 | 2274 | 0 | 0 | Link |
08.02.2024 | 08.02.2024 | Lippoldt Darin Chief Legal Officer |
Verkauf | 134.24 | 122 293 | 911 | 0 | 0 | Link |
06.02.2024 | 08.02.2024 | ABERNETHY MATT Chief Financial Officer |
Verkauf | 142.19 | 182 003 | 1280 | 0 | 0 | Link |
06.02.2024 | 08.02.2024 | BENEVICH ERIC Chief Commercial Officer |
Verkauf | 142.12 | 181 914 | 1280 | 0 | 0 | Link |
06.02.2024 | 08.02.2024 | Gano Kyle Chief Business Development Off |
Verkauf | 142.2 | 227 520 | 1600 | 0 | 0 | Link |
06.02.2024 | 08.02.2024 | GORMAN KEVIN CHARLES Chief Executive Officer |
Verkauf | 142.18 | 432 227 | 3040 | 0 | 0 | Link |
02.01.2024 | 04.01.2024 | Gano Kyle Chief Business Development Off |
Verkauf | 131.47 | 9 860 250 | 75000 | 0 | -0.08 | Link |
02.01.2024 | 04.01.2024 | Gano Kyle Chief Business Development Off |
Kaufen | 19.59 | 1 469 250 | 75000 | 0 | 0.08 | Link |
08.12.2023 | 11.12.2023 | ROBERTS EIRY Chief Medical Officer |
Verkauf | 120.1 | 36 030 | 300 | 0 | 0 | Link |
08.12.2023 | 11.12.2023 | ROBERTS EIRY Chief Medical Officer |
Kaufen | 81.05 | 24 315 | 300 | 0 | 0 | Link |
07.12.2023 | 11.12.2023 | ROBERTS EIRY Chief Medical Officer |
Verkauf | 120.37 | 9 314 110 | 77379 | 0 | -0.08 | Link |
07.12.2023 | 11.12.2023 | ROBERTS EIRY Chief Medical Officer |
Kaufen | 78.52 | 6 075 800 | 77379 | 0 | 0.08 | Link |
06.12.2023 | 08.12.2023 | Lippoldt Darin Chief Legal Officer |
Verkauf | 119.86 | 2 496 680 | 20830 | 0 | -0.02 | Link |
06.12.2023 | 08.12.2023 | Lippoldt Darin Chief Legal Officer |
Kaufen | 43.24 | 900 689 | 20830 | 0 | 0.02 | Link |
21.08.2023 | 23.08.2023 | ABERNETHY MATT Chief Financial Officer |
Verkauf | 107.39 | 228 955 | 2132 | 0 | 0 | Link |
21.08.2023 | 23.08.2023 | BENEVICH ERIC Chief Commercial Officer |
Verkauf | 107.4 | 171 840 | 1600 | 0 | 0 | Link |
21.08.2023 | 23.08.2023 | Boyer David W. Chief Corp. Affairs Officer |
Verkauf | 107.41 | 171 856 | 1600 | 0 | 0 | Link |
03.01.2023 | 05.01.2023 | POPS RICHARD F Director |
Verkauf | 119.2 | 1 788 000 | 15000 | 0 | -0.02 | Link |
03.01.2023 | 05.01.2023 | POPS RICHARD F Director |
Kaufen | 12.71 | 190 650 | 15000 | 0 | 0.02 | Link |
03.01.2023 | 05.01.2023 | SHERWIN STEPHEN A Director |
Verkauf | 118.86 | 3 565 800 | 30000 | 0 | -0.03 | Link |
03.01.2023 | 05.01.2023 | SHERWIN STEPHEN A Director |
Kaufen | 12.85 | 385 500 | 30000 | 0 | 0.03 | Link |
29.11.2022 | 01.12.2022 | Onyia Jude Chief Scientific Officer |
Verkauf | 121.9 | 284 149 | 2331 | 0 | 0 | Link |
03.11.2022 | 04.11.2022 | Cooke Julie Chief Human Resources Officer |
Verkauf | 125 | 908 000 | 7264 | 0 | -0.01 | Link |
03.11.2022 | 04.11.2022 | Cooke Julie Chief Human Resources Officer |
Kaufen | 81.05 | 588 747 | 7264 | 0 | 0.01 | Link |
02.11.2022 | 04.11.2022 | Cooke Julie Chief Human Resources Officer |
Verkauf | 124.97 | 142 966 | 1144 | 0 | 0 | Link |
02.11.2022 | 04.11.2022 | Cooke Julie Chief Human Resources Officer |
Kaufen | 81.05 | 92 721 | 1144 | 0 | 0 | Link |
26.10.2022 | 28.10.2022 | Lippoldt Darin Chief Legal Officer |
Verkauf | 115.02 | 583 957 | 5077 | 0 | -0.01 | Link |
04.10.2022 | 05.10.2022 | LYONS GARY A Director |
Verkauf | 110.54 | 552 700 | 5000 | 0 | -0.01 | Link |
03.10.2022 | 05.10.2022 | Boyer David W. Chief Corp. Affairs Officer |
Verkauf | 106.59 | 153 170 | 1437 | 0 | 0 | Link |
25.04.2022 | 27.04.2022 | LYONS GARY A Director |
Verkauf | 92.76 | 1 391 400 | 15000 | 0 | -0.02 | Link |
25.04.2022 | 27.04.2022 | LYONS GARY A Director |
Kaufen | 6.66 | 99 900 | 15000 | 0 | 0.02 | Link |
05.01.2022 | 07.01.2022 | Gano Kyle Chief Business Development Off |
Verkauf | 85.5 | 2 416 740 | 28266 | 0 | -0.03 | Link |
05.01.2022 | 07.01.2022 | Gano Kyle Chief Business Development Off |
Kaufen | 8.66 | 244 784 | 28266 | 0 | 0.03 | Link |
12.11.2020 | 16.11.2020 | ABERNETHY MATT Chief Financial Officer |
Verkauf | 90.74 | 204 800 | 2257 | 0 | 0 | Link |
12.11.2020 | 16.11.2020 | Bozigian Haig P. Chief Development Officer |
Verkauf | 90.74 | 204 800 | 2257 | 0 | 0 | Link |
12.11.2020 | 16.11.2020 | Cooke Julie Chief Human Resources Officer |
Verkauf | 90.73 | 204 778 | 2257 | 0 | 0 | Link |
12.11.2020 | 16.11.2020 | Gano Kyle Chief Business Development Off |
Verkauf | 90.73 | 204 778 | 2257 | 0 | 0 | Link |
02.11.2020 | 04.11.2020 | BENEVICH ERIC Chief Commercial Officer |
Verkauf | 96.53 | 1 988 040 | 20595 | 0 | -0.02 | Link |
02.11.2020 | 04.11.2020 | BENEVICH ERIC Chief Commercial Officer |
Kaufen | 35.99 | 741 214 | 20595 | 0 | 0.02 | Link |
Institutionen | Volumen | Aktie, % |
---|---|---|
Blackrock Inc. | 13647891 | 13.72 |
Vanguard Group Inc | 9710328 | 9.76 |
State Street Corporation | 4063336 | 4.08 |
Bellevue Group AG | 2430500 | 2.44 |
Morgan Stanley | 2326294 | 2.34 |
Renaissance Technologies, LLC | 1988546 | 2 |
JP Morgan Chase & Company | 1735543 | 1.74 |
Geode Capital Management, LLC | 1623124 | 1.63 |
Janus Henderson Group PLC | 1551367 | 1.56 |
Price (T.Rowe) Associates Inc | 1476949 | 1.48 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Mr. Matthew C. Abernethy | Chief Financial Officer | 1.04M | 1980 (44 Jahr) |
Mr. Eric S. Benevich | Chief Commercial Officer | 805k | 1965 (59 Jahre) |
Jane Sorensen | Head of Investor Relations | N/A | |
Ms. Julie S. Cooke | Chief Human Resources Officer | N/A | 1966 (58 Jahre) |
Dr. Kevin C. Gorman Ph.D. | CEO & Director | 1.9M | 1958 (66 Jahre) |
Dr. Jude Onyia Ph.D. | Chief Scientific Officer | 621.66k | 1964 (60 Jahre) |
Dr. Eiry Wyn Roberts M.D. | Chief Medical Officer | 1.04M | 1964 (60 Jahre) |
Mr. Darin M. Lippoldt Esq. | Chief Legal Officer & Corporate Secretary | 921.01k | 1966 (58 Jahre) |
Mr. Kyle W. Gano Ph.D. | Chief Business Development & Strategy Officer | 921.52k | 1973 (51 Jahr) |
Mr. David Warren Boyer | Chief Corporate Affairs Officer | N/A | 1980 (44 Jahr) |
Adresse: United States, San Diego, CA , 12780 El Camino Real - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: http://www.neurocrine.com
Webseite: http://www.neurocrine.com